LianBio Noncontrolling Interest, Increase from Subsidiary Equity Issuance
LianBio (LIANY) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $9.41 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-28.
Discontinued › Shareholders' Equity
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2023-03-28
- LianBio noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2021-03-31 was $9.41M.
- LianBio noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2020-09-30 was $33.77M.
- LianBio noncontrolling interest, increase from subsidiary equity issuance for fiscal 2021 was $9.41M, a 72.12% decline from fiscal 2020.
- LianBio noncontrolling interest, increase from subsidiary equity issuance for fiscal 2020 was $33.77M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|
| 2021-12-31 | $9.41M 10-K · filed 2023-03-28 | |
| 2021-03-31 | $9.41M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $33.77M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $33.77M 10-Q/A · filed 2022-01-10 |